3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
3
Phase 1
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Endocrine
1
Conditions
Carcinoma, Non-Small-Cell Lung
375
Neoplasms
325
Neoplasm Metastasis
290
Leukemia, Myeloid, Acute
282
Breast Neoplasms
277
Colorectal Neoplasms
239
Melanoma
197
Ovarian Neoplasms
193
Recurrence
187
Multiple Myeloma
181
Prostatic Neoplasms
157
Pancreatic Neoplasms
156
Lung Neoplasms
156
Squamous Cell Carcinoma of Head and Neck
150
Lymphoma, Non-Hodgkin
146
Glioblastoma
145
Triple Negative Breast Neoplasms
120
Myelodysplastic Syndromes
117
Carcinoma, Renal Cell
111
Stomach Neoplasms
110
Glioma
108
Advanced Solid Tumors
108
Brain Neoplasms
105
Precursor Cell Lymphoblastic Leukemia-Lymphoma
104
Lymphoma
103
Lymphoma, Large B-Cell, Diffuse
102
Lymphoma, B-Cell
98
Carcinoma, Hepatocellular
95
Endometrial Neoplasms
92
Lymphoma, Follicular
91
Interventions
osimertinib
1
cemiplimab
1
Vascular Endothelial Growth Factor A
1
Paclitaxel
1
Docetaxel
1
Carboplatin
1
Antibodies, Bispecific
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Lethal Congenital Contracture Syndrome 2
×
1 year
×
Clear all
NCT05142189
2026-04-14
LuCa-MERIT-1
BioNTech SE
Phase 1
Recruiting
320 enrolled